Iron Overload Decreases Ca V 1.3-Dependent L-Type Ca 2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation
Authors:
- Robert A. RoseRRRobert A. Rose
- Michael SellanMSMichael Sellan
- Jeremy A. SimpsonJSJeremy A. Simpson
- Farzad IzaddoustdarFIFarzad Izaddoustdar
- Carlo CifelliCCCarlo Cifelli
- Brian K. PanamaBPBrian K. Panama
- Mark DavisMDMark Davis
- Dongling ZhaoDZDongling Zhao
- Moniba MarkhaniMMMoniba Markhani
- Geoffrey G. MurphyGMGeoffrey G. Murphy
- Joerg StriessnigJSJoerg Striessnig
- Peter P. LiuPLPeter P. Liu
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 4 (5) , 733-742
Abstract
Background—: Chronic iron overload (CIO) is associated with blood disorders such as thalassemias and hemochromatosis. A major prognostic indicator of survival in patients with CIO is iron-mediated cardiomyopathy characterized by contractile dysfunction and electrical disturbances, including slow heart rate (bradycardia) and heart block. Methods and Results—: We used a mouse model of CIO to investigate the effects of iron on sinoatrial node (SAN) function. As in humans, CIO reduced heart rate (≈20%) in conscious mice as well as in anesthetized mice with autonomic nervous system blockade and in isolated Langendorff-perfused mouse hearts, suggesting that bradycardia originates from altered intrinsic SAN pacemaker function. Indeed, spontaneous action potential frequencies in SAN myocytes with CIO were reduced in association with decreased L-type Ca 2+ current (I Ca,L ) densities and positive (rightward) voltage shifts in I Ca,L activation. Pacemaker current (I f ) was not affected by CIO. Because I Ca,L in SAN myocytes (as well as in atrial and conducting system myocytes) activates at relatively negative potentials due to the presence of Ca V 1.3 channels (in addition to Ca V 1.2 channels), our data suggest that elevated iron preferentially suppresses Ca V 1.3 channel function. Consistent with this suggestion, CIO reduced Ca V 1.3 mRNA levels by ≈40% in atrial tissue (containing SAN) and did not lower heart rate in Ca V 1.3 knockout mice. CIO also induced PR-interval prolongation, heart block, and atrial fibrillation, conditions also seen in Ca V 1.3 knockout mice. Conclusions—: Our results demonstrate that CIO selectively reduces Ca V 1.3-mediated I Ca,L , leading to bradycardia, slowing of electrical conduction, and atrial fibrillation as seen in patients with iron overload.Keywords
This publication has 46 references indexed in Scilit:
- Remission of paroxysmal atrial fibrillation with iron reduction in haemophilia AHaemophilia, 2010
- Impaired Ca2+ homeostasis is associated with atrial fibrillation in the α1D L-type Ca2+ channel KO mouseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- RGS4 Regulates Parasympathetic Signaling and Heart Rate Control in the Sinoatrial NodeCirculation Research, 2008
- Altered Heart Rate and Sinoatrial Node Function in Mice Lacking the cAMP Regulator Phosphoinositide 3-Kinase-γCirculation Research, 2007
- SCN5A and sinoatrial node pacemaker functionCardiovascular Research, 2007
- Iron-mediated cardiovascular injuryVascular Medicine, 1999
- Cardiac iron overload in thalassemic patients: An endomyocardial biopsy studyAnnals of Hematology, 1995
- Iron in the heartThe American Journal of Medicine, 1971
- Histochemical Studies of the Myocardium and Conduction System in Acquired Iron-Storage DiseaseCirculation, 1967
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964